Nephrology Doctors in North Kansas City, MO Accepting Medicare

3 Nephrology doctors found. Showing 1 - 3

Kamel Hatahet, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2790 Clay Edwards Dr Ste 410, North Kansas City, MO 64116 Phone: 816-474-9353    Fax: 816-474-3627

Dr. Justin Thomas Teiwes, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2790 Clay Edwards Dr, Suite 410, North Kansas City, MO 64116 Phone: 816-474-9353    Fax: 816-474-3627

Dr. Suleiman Daifallah, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2790 Clay Edwards Dr, Suite 410, North Kansas City, MO 64116 Phone: 816-474-9353

News Archive

Hypertonic fluids do not improve outcomes or survival for severe traumatic brain injury: Study

Patients with a severe traumatic brain injury (and not in shock because of blood loss) who received out-of-hospital administration of hypertonic fluids (a solution with increased concentration of certain electrolytes and thought to help reduce intracranial pressure) as initial resuscitation did not experience better 6-month neurologic outcomes or survival compared to patients who received a normal saline solution, according to a study in the October 6 issue of JAMA.

BSD's MicroThermX Microwave Ablation System featured at CIRSE

BSD Medical Corporation announced today that the MicroThermX Microwave Ablation System was featured at the Company's exhibition booth at the international meeting of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE), which was held in Valencia, Spain, October 2-6, 2010.

Special article says that experience can help public health personnel prepare for affordable care act

How will full implementation of the Affordable Care Act affect the work and goals of state and local public health departments-and how can public health personnel contribute to the success of health care reform? The experience in Massachusetts has some important lessons, according to an article published online by the Journal of Public Health Management and Practice.

Myriad and Clovis ink deal on FDA-approved BRACAnalysis CDx test to identify patients with germline BRCA mutations for rucaparib treatment

Myriad Genetics, Inc. and Clovis Oncology, Inc. have announced a companion diagnostic collaboration to support a post-marketing regulatory commitment related to Clovis' PARP inhibitor, Rubraca. Financial terms of the deal were not disclosed.

New technologies can screen for cervical cancer better than Pap smears

Emerging technologies can screen for cervical cancer better than Pap smears and, if widely used, could save lives both in developing nations and parts of countries, like the United States, where access to health care may be limited.

Read more Medical News

› Verified 7 days ago